By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


miRagen Therapeutics 

6200 Lookout Road
Suite 100
Boulder  Colorado  80301  U.S.A.
Phone: 303-531-5952 Fax: 303-531-5094


Start Up

Company News
miRagen Initiates First Clinical Trial For MRG-106 In Lymphoma Patients 3/2/2016 11:02:22 AM
miRagen Initiates First Clinical Trial For Anti-Fibrosis Product Candidate MRG-201 11/12/2015 12:15:31 PM
miRagen Bags $41 Million to Advance Two MicroRNA Programs into Clinical Trials 11/10/2015 5:59:24 AM
Research Findings Demonstrate miRagen Therapeutics’ Drug Reverses Pulmonary Fibrosis 9/22/2014 6:19:28 AM
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease 6/23/2014 8:26:32 AM
miRagen Therapeutics Expands Executive Leadership Team Adding Drug Development Veteran 3/25/2014 7:30:07 AM
miRagen Therapeutics Adds Biotech and Pharmaceutical Industry Veterans to Senior Leadership Team 6/11/2013 6:55:59 AM
miRagen Therapeutics Achieves First Milestone in Strategic Alliance With Servier 5/23/2013 10:59:42 AM
miRagen Therapeutics Exclusively Licenses Intellectual Property From the University of Glasgow for microRNA-145 Targeting in the Treatment of Pulmonary Arterial Hypertension 3/5/2013 9:44:01 AM
Santaris Pharma A/S and miRagen Therapeutics Expand Worldwide Strategic Alliance to Discover and Develop LNA-Drugs Against Disease Causing Micrornas 1/8/2013 9:56:12 AM